The first volunteers in a large-scale trial of Moderna's mRNA-based vaccine against bird flu – long considered to be a ...

Sarclisa (isatuximab) has been approved in the US since 2020, initially for relapsed/refractory multiple myeloma before ...

The oral BTK inhibitor race in RMS is now a two-horse affair, with fenebrutinib vying against Novartis' remibrutinib, already ...

MSD has agreed a deal with Google Cloud that will put the tech giant's AI tools in the hands of its 75,000 employees ...

The first recipients of funding under the UK government's £500 million Sovereign AI programme have been announced, intended ...

As proven by the news of Merck and NVidia’s new partnership, for example. But while the idea of using AI for drug discovery ...

Too many patient access strategies stop at “script filled”. But this approach is ultimately short-sighted, failing to build ...

The Trump administration has extended the duration of a pilot programme to provide access to obesity drugs through Medicare, ...

Roche could be just months away from an FDA approval of Gazyva as the first anti-CD20 therapy for systemic lupus ...

Novo Nordisk acquired rights to etavopivat when it bought Forma Therapeutics for $1.1 billion in 2022, when the drug was in ...

In the pharmaceutical and healthcare sectors, where precision is paramount and human lives are directly impacted, these ...

After years of constrained capital markets, biotech companies are operating in an environment where even late-stage ...